NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









A3P Biomedical

A3P Biomedical

Private
StockholmHealthcare & Life Scienceshttps://www.a3p.com/

Last Round

Private Placement

May 5, 2022

Est. Valuation

$120.84M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

A3P Biomedical is a medical technology company that develops diagnostic tests for the early detection of prostate cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

prostate cancer screeningmolecular diagnosticsliquid biopsyprostate-specific antigenPSAprecision medicinerisk assessmentpredictive algorithmclinical decision supportbiomarker testingpolygenic risk scorediagnostic laboratorymedtechhealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

A3P Biomedical Comparables

Compare A3P Biomedical with similar companies based on industry and business-model similarity.

A3P Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MDxHealth
80%
OPKO Health
78%
Onconetix, Inc.
76%

A3P Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementMay 5, 2022
Private PlacementOct 21, 2020

A3P Biomedical Investors

Notable investors and investment history

A3P Biomedical investors
InvestorRounds
Inbox CapitalPrivate Placement
TomEnterprisePrivate Placement
Stena SessanPrivate Placement
The Foundation for Baltic and East European StudiesPrivate Placement
Flerie ABPrivate Placement

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 5, 2026

    Monthly visitors increased 794% MoM.

  • Dec 2, 2025

    Monthly visitors increased 156% MoM.

A3P Biomedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

A3P Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about A3P Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersStockholm
Employee Range43
Year Founded2018
Last FundingMay 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.